|
All Toxicology
Citations 81-88 of 88 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning
- R. B. Parkinson, R. O. Hopkins, H. B. Cleavinger, L. K. Weaver, J. Victoroff, J. F. Foley, and E. D. Bigler
Neurology 2002; 58: 1525-1532.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cannabinoids in MS: Potentially useful but not just yet!
- Alan J. Thompson and David Baker
Neurology 2002; 58: 1323-1324.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
- J. Killestein, E. L.J. Hoogervorst, M. Reif, N. F. Kalkers, A. C. van Loenen, P. G.M. Staats, R. W. Gorter, B. M.J. Uitdehaag, and C. H. Polman
Neurology 2002; 58: 1404-1407.
[Abstract]
[Full text]
[PDF]
- MEDICAL HYPOTHESIS
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
- Paul Alan Cox and Oliver W. Sacks
Neurology 2002; 58: 956-959.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Disopyramide-induced neuropathy
- Chiara Briani, Gabriella Zara, and Paolo Negrin
Neurology 2002; 58: 663.
[Full text]
[PDF]
- ARTICLES
Head growth and neurodevelopment of infants born to HIV-1–infected drug-using women
- C. Macmillan, L.S. Magder, P. Brouwers, C. Chase, J. Hittelman, T. Lasky, K. Malee, C.A. Mellins, and J. Velez–Borras
Neurology 2001; 57: 1402-1411.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Amantadine-induced cortical myoclonus
- K. Matsunaga, T. Uozumi, L. Qingrui, T. Hashimoto, and S. Tsuji
Neurology 2001; 56: 279-280.
[Full text]
[PDF]
- ARTICLES
Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
- B. A. Racette, L. McGee-Minnich, S. M. Moerlein, J. W. Mink, T. O. Videen, and J. S. Perlmutter
Neurology 2001; 56: 8-13.
[Abstract]
[Full text]
[PDF]
|
|
